An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score.

OBJECTIVE The metabolic syndrome (MetS) is typically diagnosed based on abnormalities in specific clustered clinical measures that are associated with increased risk for coronary heart disease (CHD) and Type 2 diabetes mellitus (T2DM). However, current MetS criteria result in racial/ethnic discrepancies. Our goals were to use confirmatory factor analysis (CFA) to delineate differential contributions to MetS by sub-group, and if contributions were discovered, develop sex and racial/ethnic-specific equations to calculate MetS severity. RESEARCH DESIGN AND METHODS Using data on adults from the National Health and Nutrition Examination Survey 1999-2010, we performed a CFA of a single MetS factor that allowed differential loadings across groups, resulting in a sex and race/ethnicity-specific continuous MetS severity score. RESULTS Loadings to the single MetS factor differed by sub-group for each MetS component (p<0.001), with lower factor loadings among non-Hispanic-blacks for triglycerides and among Hispanics for waist circumference. Systolic blood pressure exhibited low factor loadings among all groups. MetS severity scores were correlated with biomarkers of future disease (high-sensitivity C-reactive-protein, uric acid, insulin resistance). Non-Hispanic-black-males with diabetics had a low prevalence of MetS but high MetS severity scores that were not significantly different from other racial/ethnic groups. CONCLUSIONS This analysis among adults uniquely demonstrated differences between sexes and racial/ethnic groups regarding contributions of traditional MetS components to an assumed single factor. The resulting equations provide a clinically-accessible and interpretable continuous measure of MetS for potential use in identifying adults at higher risk for MetS-related diseases and following changes within individuals over time. These equations hold potential to be a powerful new outcome for use in MetS-focused research and interventions.

[1]  P. Allhoff,et al.  Bogalusa Heart Study , 2020, Encyclopedia of Behavioral Medicine.

[2]  M. Gurka,et al.  Diagnosis of the Metabolic Syndrome Is Associated With Disproportionately High Levels of High-Sensitivity C-Reactive Protein in Non–Hispanic Black Adolescents , 2011, Diabetes Care.

[3]  Gerald S. Berenson,et al.  Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. , 1994, Archives of internal medicine.

[4]  U. Ekelund,et al.  Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study) , 2006, The Lancet.

[5]  M. DeBoer.  Underdiagnosis of Metabolic Syndrome in Non-Hispanic Black Adolescents: A Call for Ethnic-Specific Criteria , 2010, Current cardiovascular risk reports.

[6]  C. Cowie,et al.  Ethnic differences in the ability of triglyceride levels to identify insulin resistance. , 2008, Atherosclerosis.

[7]  P. Bentler,et al.  Cutoff criteria for fit indexes in covariance structure analysis : Conventional criteria versus new alternatives , 1999 .

[8]  Insulin secretion and sensitivity in black versus white prepubertal healthy children. , 1997, The Journal of clinical endocrinology and metabolism.

[9]  M. Gurka,et al.  Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006. , 2012, Metabolism: clinical and experimental.

[10]  E. Ingelsson,et al.  Impact of BMI and the Metabolic Syndrome on the Risk of Diabetes in Middle-Aged Men , 2010, Diabetes Care.

[11]  A. Sumner.  Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. , 2009, The Journal of pediatrics.

[12]  Hyon K. Choi,et al.  Serum Concentrations of Uric Acid and the Metabolic Syndrome Among US Children and Adolescents , 2007, Circulation.

[13]  L. Bouter,et al.  Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study , 2005, Circulation.

[14]  SoJung Lee,et al.  Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. , 2006, Diabetes care.

[15]  Kai I Cheang,et al.  Comparison of different metabolic syndrome definitions and risks of incident cardiovascular events in the elderly. , 2012, Metabolism: clinical and experimental.

[16]  M. Gurka,et al.  Low sensitivity for the metabolic syndrome to detect uric acid elevations in females and non-Hispanic-black male adolescents: an analysis of NHANES 1999-2006. , 2012, Atherosclerosis.

[17]  Udo Hoffmann,et al.  Abdominal Subcutaneous and Visceral Adipose Tissue and Insulin Resistance in the Framingham Heart Study , 2010, Obesity.

[18]  F. Rodríguez‐Artalejo,et al.  Validity of a Single-Factor Model Underlying the Metabolic Syndrome in Children , 2010, Diabetes Care.

[19]  D. Schuster,et al.  Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome. , 2010, Metabolism: clinical and experimental.

[20]  F. Cuccurullo,et al.  Prognostic relevance of metabolic syndrome in hypertensive patients at low-to-medium risk. , 2007, American journal of hypertension.

[21]  Ke-Hai Yuan,et al.  On Chi-Square Difference and z Tests in Mean and Covariance Structure Analysis when the Base Model is Misspecified , 2004 .

[22]  A. Onat,et al.  Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk. , 2011, Metabolism: clinical and experimental.

[23]  Avron Spiro,et al.  Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. , 2003, American journal of epidemiology.

[24]  E. Ford,et al.  Is There a Single Underlying Factor for the Metabolic Syndrome in Adolescents? , 2007, Diabetes Care.

[25]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[26]  A. Karter,et al.  Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study , 2005, Circulation.

[27]  Bernard V. Miller,et al.  Metabolic Syndrome Does Not Detect Metabolic Risk in African Men Living in the U.S. , 2011, Diabetes Care.

[28]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[29]  Shankuan Zhu,et al.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of internal medicine.

[30]  Ali H. Mokdad,et al.  State of Disparities in Cardiovascular Health in the United States , 2005, Circulation.

[31]  M. Federici,et al.  Cytokines and metabolic syndrome: the perfect storm for arterial aging. , 2011, Atherosclerosis.

[32]  Laura M. Stapleton,et al.  Re: "(Mis)use of factor analysis in the study of insulin resistance syndrome". , 2005, American journal of epidemiology.

[33]  H. Drexel,et al.  Roles of the Metabolic Syndrome, HDL Cholesterol, and Coronary Atherosclerosis in Subclinical Inflammation , 2010, Diabetes Care.

[34]  M. N. Oliver,et al.  Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[35]  W. Kannel,et al.  Elevated systolic blood pressure as a cardiovascular risk factor. , 2000, The American journal of cardiology.

[36]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[37]  R. Santos,et al.  Uric acid: A marker of increased cardiovascular risk. , 2009, Atherosclerosis.

[38]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[39]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[40]  M. Gurka,et al.  Racial/ethnic and sex differences in the ability of metabolic syndrome criteria to predict elevations in fasting insulin levels in adolescents. , 2011, The Journal of pediatrics.

[41]  J. Eisenmann,et al.  On the use of a continuous metabolic syndrome score in pediatric research , 2008, Cardiovascular diabetology.

[42]  H. Uzun,et al.  The association of oxidative stress markers with conventional risk factors in the metabolic syndrome. , 2013, Metabolism: clinical and experimental.

[43]  Shumei S. Sun,et al.  A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences , 2012, Cardiovascular Diabetology.